The diagnostic value of the combination of carcinoembryonic antigen, squamous cell carcinoma-related antigen, CYFRA 21-1, neuron-specific enolase, tissue polypeptide antigen, and progastrin-releasing peptide in small cell lung cancer discrimination - Concepedia

Concepedia

Publication | Open Access

The diagnostic value of the combination of carcinoembryonic antigen, squamous cell carcinoma-related antigen, CYFRA 21-1, neuron-specific enolase, tissue polypeptide antigen, and progastrin-releasing peptide in small cell lung cancer discrimination

DOI Full Paper Access

31

Citations

29

References

2021

Year

Zhimao Chen, Xiangzheng Liu, Xueqian Shang, Qi Kang, Shijie Zhang

The International Journal of Biological Markers

Abstract

Combining tumor markers can improve the efficacy for small cell lung cancer discrimination. A predictive model has been established in small cell lung cancer differential diagnosis with preferable efficacy.

References

	Year	Citations
Cancer statistics, 2016 Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal CA A Cancer Journal for Clinicians	2016	16.1K
Changing Epidemiology of Small-Cell Lung Cancer in the United States Over the Last 30 Years: Analysis of the Surveillance, Epidemiologic, and End Results Database Ramaswamy Govindan, Nathan Page, Daniel Morgensztern, Journal of Clinical Oncology	2006	1.8K
Establishing the Diagnosis of Lung Cancer M. Patricia Rivera, Atul C. Mehta, Momen M. Wahidi CHEST Journal MedicineMultiple Pulmonary NoduleDiagnosisPathologyCancer Diagnosis	2013	1K
Management of Lung Nodules Detected by Volume CT Scanning Rob J. van Klaveren, Matthijs Oudkerk, Mathias Prokop, New England Journal of Medicine	2009	816
Small Cell Lung Cancer Gregory P. Kalemkerian, Wallace Akerley Journal of the National Comprehensive Cancer Network Surgical OncologySclc FocusCancer ManagementPathologyTumor Biology	2013	449
Lung cancer — major changes in the American Joint Committee on Cancer eighth edition cancer staging manual Ramón Rami–Porta, Hisao Asamura, William D. Travis, CA A Cancer Journal for Clinicians Surgical OncologyAmerican Joint CommitteeCancer ManagementPathologyCancer Registration	2017	424
Diagnostic value of CEA and CYFRA 21-1 tumor markers in primary lung cancer Kyoko Okamura, Koichi Takayama, Miiru Izumi, Lung Cancer OncologyCancer DetectionMedicineMultiple Pulmonary NodulePrimary Lung Cancer	2013	230
Assessment of a Combined Panel of Six Serum Tumor Markers for Lung Cancer Rafael Molina, Ramón M. Marrades, Josep M. Augé, American Journal of Respiratory and Critical Care Medicine	2015	184
Mucins CA 125, CA 19.9, CA 15.3 and TAG-72.3 as Tumor Markers in Patients with Lung Cancer: Comparison with CYFRA 21-1, CEA, SCC and NSE Rafael Molina, José Maria Augé, José Miguel Escudero Fernández, Tumor Biology	2008	122
Usefulness of Serum Tumor Markers, Including Progastrin-Releasing Peptide, in Patients with Lung Cancer: Correlation with Histology Rafael Molina, Josep M. Aug eacute, Xavier Bosch, Tumor Biology	2009	114

Page 1